| 产品详情 |
| Edit |   |
|---|
| Product Name | HA1077 |
|---|
| Description | Purity ~99%. The monohydrochloride salt is the form used to prepare formulations of this drug for clinical use. Note that the solubility properties of the mono- and di-HCl salts are different. Kinase inhibitor; has antivasospastic properties. Solubility: Very soluble in water, up to 200mg/ml or more; soluble in DMSO up to about 10mg/ml; not soluble in ethanol; addition of an aqueous solution of this dihydrochloride salt into a buffer solution may significantly alter its solubility. |
|---|
| Size | 250mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | HA1077 (Fasudil, 1-(5-Isoquinolinesulfonyl)-1H-hexahydro-1,4-diazepine•2HCl, 1-(5-Isoquinolinesulfonyl) Homopiperazine•2HCl) |
|---|
| Gene, Accession, CAS # | n/a |
|---|
| Catalog # | H1000-01 |
|---|
| Price | |
|---|
| Order / More Info | HA1077 from UNITED STATES BIOLOGICAL |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|